Adcytherix
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.
Leadership & Board
- Current Number of Employees
- 24
- Current LinkedIn Followers
- 3,520
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $105M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $105M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
Adcytherix had 24 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
24Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Adcytherix had 3,520 followers as of October 12, 2026. The number of followers increased by 21 (0.60%) week-over-week.
3,520Latest Followers Count
21(0.60%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 16, 2025 | Series A | $105.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| RA Capital Management | Series A |
| aMoon | Series A |
| Andera Partners | Series A |
| Surveyor Capital | Series A |
| Pureos Bioventures | Series A |
| Kurma Partners | Series A |
| Angelini Ventures | Series A |
| Bpifrance | Series A |
Similar Companies
A snapshot of private companies similar to Adcytherix, helping you discover and navigate related company profiles.
Related News and Analysis
